RNA Technologies Expand Tool Kit for Cancer Immunotherapy

Elie Dolgin • October 1, 2019

Multiple companies are pursuing mRNA-based medicines that harness the body's protein-making machinery to transform lab-synthesized nucleotides into cancer-associated antigens, in the case of vaccines, or immune-stimulating molecules, in the case of therapeutics. Several candidates from BioNTech and Moderna have shown promise in early-stage testing.

Continue reading at Cancer Discovery.

Blue and gold fibrous texture in the shape of brain
By Elie Dolgin June 30, 2025
AI and real-time neural feedback could transform treatments.
Damaged 15th century painting by the Master of the Prado Adoration of the Magi
By Elie Dolgin June 12, 2025
Pixels meet paint, as a digital “mask” conceals damage on a 15th-century painting.